• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

土耳其多药耐药鲍曼不动杆菌分离株的替加环素药敏性。

Tigecycline susceptibility in multidrug resistant Acinetobacter isolates from Turkey.

机构信息

Ege University Faculty of Pharmacy, Dep. of Pharmaceutical Microbiology, Izmir, Türkiye.

lzmir Katip Celebi University, Atatürk Training and Research Hospital Medical Microbiology Laboratory, Izmir, Türkiye.

出版信息

Pol J Microbiol. 2013;62(3):295-8.

PMID:24459835
Abstract

The present study aimed to evaluate antimicrobial activity of tigecydcline against 84 multidrug resistant (MDR) Acinetobacter spp. strains by disc diffusion and E-test methods. The results of disc diffusion test were compared according to two different interpretation ways. In addition, E-test results and the disc diffusion results that interpreted by both the methods were checked for compatibility. According to the disc diffusion test, 3 strains (3.57%) were found resistant to tigecycline when considering breakpoints suggested by Food and Drug Administration (FDA). On the other hand, none of the strains was found resistant to the evaluation criteria recommended by Jones etal. (2007). Considering E-test results of tigecycline, MIC, and MICG, values of tigecycline for Acinetobacter spp. were 0.75 and 1 mg/l, respectively. Based on FDA defined breakpoints for Enterobacteriaceae, any resistant isolate was detected. In conclusion, although there are some differences in the results, tigecycline was found quite effective on Acinetobacter spp. isolates with reference to the both disc diffusion and the E-test methods.

摘要

本研究旨在通过纸片扩散和 E 试验方法评估替加环素对 84 株多药耐药(MDR)不动杆菌属菌株的抗菌活性。根据两种不同的解释方法比较了纸片扩散试验的结果。此外,还检查了 E 试验结果和两种方法解释的纸片扩散结果的兼容性。根据纸片扩散试验,当考虑到食品和药物管理局(FDA)建议的折点时,发现 3 株(3.57%)菌株对替加环素耐药。另一方面,根据 Jones 等人推荐的评估标准(2007 年),没有一株对替加环素耐药。考虑替加环素的 E 试验结果、MIC 和 MICG 值,替加环素对不动杆菌属的 MIC 值分别为 0.75 和 1mg/L。根据 FDA 定义的肠杆菌科折点,检测到任何耐药分离株。总之,尽管结果存在一些差异,但参照纸片扩散和 E 试验方法,替加环素对不动杆菌属分离株的疗效相当显著。

相似文献

1
Tigecycline susceptibility in multidrug resistant Acinetobacter isolates from Turkey.土耳其多药耐药鲍曼不动杆菌分离株的替加环素药敏性。
Pol J Microbiol. 2013;62(3):295-8.
2
Multicenter studies of tigecycline disk diffusion susceptibility results for Acinetobacter spp.针对不动杆菌属的替加环素纸片扩散药敏结果的多中心研究
J Clin Microbiol. 2007 Jan;45(1):227-30. doi: 10.1128/JCM.01588-06. Epub 2006 Nov 8.
3
In vitro activity of tigecycline as a therapeutic option against multidrug-resistant Acinetobacter spp.替加环素作为治疗多重耐药不动杆菌属细菌的一种治疗选择的体外活性
New Microbiol. 2008 Oct;31(4):535-42.
4
Emergence of tigecycline and colistin resistance in Acinetobacter species isolated from patients in Kuwait hospitals.科威特医院患者分离出的不动杆菌属中替加环素和黏菌素耐药性的出现。
J Chemother. 2011 Feb;23(1):13-6. doi: 10.1179/joc.2011.23.1.13.
5
Comparative assessment of antimicrobial susceptibility testing for tigecycline and colistin against Acinetobacter baumannii clinical isolates, including multidrug-resistant isolates.比较替加环素和黏菌素对包括多重耐药株在内的鲍曼不动杆菌临床分离株的抗菌药物敏感性试验。
Int J Antimicrob Agents. 2014 Nov;44(5):396-401. doi: 10.1016/j.ijantimicag.2014.06.014. Epub 2014 Aug 4.
6
Tigecycline activity tested against multidrug-resistant Enterobacteriaceae and Acinetobacter spp. isolated in US medical centers (2005-2009).替加环素对美国医疗中心分离的多药耐药肠杆菌科和不动杆菌属的活性检测(2005-2009 年)。
Diagn Microbiol Infect Dis. 2011 Feb;69(2):223-7. doi: 10.1016/j.diagmicrobio.2010.10.020.
7
Comparative in vitro antimicrobial susceptibilities and synergistic activities of antimicrobial combinations against carbapenem-resistant Acinetobacter species: Acinetobacter baumannii versus Acinetobacter genospecies 3 and 13TU.比较耐碳青霉烯类不动杆菌属种(鲍曼不动杆菌与 3 型和 13TU 型基因种)对抗菌药物组合的体外抗微生物药敏活性和协同作用。
Diagn Microbiol Infect Dis. 2011 Jul;70(3):380-6. doi: 10.1016/j.diagmicrobio.2011.03.003. Epub 2011 May 10.
8
Antibiotic resistance among clinical isolates of Acinetobacter in the UK, and in vitro evaluation of tigecycline (GAR-936).英国不动杆菌临床分离株的抗生素耐药性及替加环素(GAR-936)的体外评估
J Antimicrob Chemother. 2002 Mar;49(3):479-87. doi: 10.1093/jac/49.3.479.
9
In vitro activity of tigecycline against colistin-resistant Acinetobacter spp. isolates from Korea.替加环素对韩国分离出的耐黏菌素不动杆菌属菌株的体外活性。
Int J Antimicrob Agents. 2009 Mar;33(3):289-90. doi: 10.1016/j.ijantimicag.2008.09.005. Epub 2008 Dec 16.
10
Tigecycline for the treatment of multidrug-resistant (including carbapenem-resistant) Acinetobacter infections: a review of the scientific evidence.替加环素治疗多重耐药(包括耐碳青霉烯类)鲍曼不动杆菌感染:科学证据综述
J Antimicrob Chemother. 2008 Jul;62(1):45-55. doi: 10.1093/jac/dkn165. Epub 2008 Apr 24.